| Home > Publications database > Interaction of Epothilone B (Patupilone) with Microtubules, As Detected by Two-Dimensional Solid-State NMR Spectroscopy > print |
| 001 | 12415 | ||
| 005 | 20200402205927.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:20809556 |
| 024 | 7 | _ | |2 DOI |a 10.1002/anie.201001946 |
| 024 | 7 | _ | |2 WOS |a WOS:000283391800021 |
| 024 | 7 | _ | |2 ISSN |a 0570-0833 |
| 037 | _ | _ | |a PreJuSER-12415 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 540 |
| 084 | _ | _ | |2 WoS |a Chemistry, Multidisciplinary |
| 100 | 1 | _ | |a Kumar, A. |b 0 |0 P:(DE-HGF)0 |
| 245 | _ | _ | |a Interaction of Epothilone B (Patupilone) with Microtubules, As Detected by Two-Dimensional Solid-State NMR Spectroscopy |
| 260 | _ | _ | |c 2010 |a Weinheim |b Wiley-VCH |
| 295 | 1 | 0 | |a . |
| 300 | _ | _ | |a 7504-7507 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |a Angewandte Chemie |x 0044-8249 |0 6077 |y 41 |v 49 |
| 500 | _ | _ | |a This research was funded by the Volkswagen Foundation. |
| 536 | _ | _ | |a Funktion und Dysfunktion des Nervensystems |c P33 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK409 |x 0 |
| 536 | _ | _ | |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |c P45 |0 G:(DE-Juel1)FUEK505 |x 1 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 2 | |2 MeSH |a Antineoplastic Agents: isolation & purification |
| 650 | _ | 2 | |2 MeSH |a Antineoplastic Agents: pharmacology |
| 650 | _ | 2 | |2 MeSH |a Epothilones: isolation & purification |
| 650 | _ | 2 | |2 MeSH |a Epothilones: pharmacology |
| 650 | _ | 2 | |2 MeSH |a Humans |
| 650 | _ | 2 | |2 MeSH |a Microtubules: metabolism |
| 650 | _ | 2 | |2 MeSH |a Microtubules: ultrastructure |
| 650 | _ | 2 | |2 MeSH |a Models, Molecular |
| 650 | _ | 2 | |2 MeSH |a Myxococcales: chemistry |
| 650 | _ | 2 | |2 MeSH |a Neoplasms: drug therapy |
| 650 | _ | 2 | |2 MeSH |a Nuclear Magnetic Resonance, Biomolecular: methods |
| 650 | _ | 2 | |2 MeSH |a Tubulin: metabolism |
| 650 | _ | 2 | |2 MeSH |a Tubulin Modulators: isolation & purification |
| 650 | _ | 2 | |2 MeSH |a Tubulin Modulators: pharmacology |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Antineoplastic Agents |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Epothilones |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Tubulin |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Tubulin Modulators |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a epothilone B |
| 650 | _ | 7 | |a J |2 WoSType |
| 653 | 2 | 0 | |2 Author |a antitumor agents |
| 653 | 2 | 0 | |2 Author |a drug binding |
| 653 | 2 | 0 | |2 Author |a microtubules |
| 653 | 2 | 0 | |2 Author |a NMR spectroscopy |
| 653 | 2 | 0 | |2 Author |a structure elucidation |
| 700 | 1 | _ | |a Heise, H. |b 1 |u FZJ |0 P:(DE-Juel1)VDB77857 |
| 700 | 1 | _ | |a Blommers, M.J.J. |b 2 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Krastel, P. |b 3 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Schmitt, E. |b 4 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Petersen, F. |b 5 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Mandelkow, E.M. |b 6 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Carlomagno, T. |b 7 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Griesinger, C. |b 8 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Baldus, M. |b 9 |0 P:(DE-HGF)0 |
| 773 | _ | _ | |0 PERI:(DE-600)2011836-3 |a 10.1002/anie.201001946 |g Vol. 49, p. 7504-7507 |p 7504-7507 |q 49<7504-7507 |t Angewandte Chemie / International edition |v 49 |x 0044-8249 |y 2010 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1002/anie.201001946 |
| 909 | C | O | |o oai:juser.fz-juelich.de:12415 |p VDB |
| 913 | 1 | _ | |k P33 |v Funktion und Dysfunktion des Nervensystems |l Funktion und Dysfunktion des Nervensystems |b Gesundheit |0 G:(DE-Juel1)FUEK409 |x 0 |
| 913 | 1 | _ | |k P45 |v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |l Biologische Informationsverarbeitung |b Schlüsseltechnologien |0 G:(DE-Juel1)FUEK505 |x 1 |
| 913 | 2 | _ | |a DE-HGF |b Key Technologies |l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-551 |2 G:(DE-HGF)POF3-500 |v Functional Macromolecules and Complexes |x 0 |
| 914 | 1 | _ | |y 2010 |
| 915 | _ | _ | |a JCR/ISI refereed |0 StatID:(DE-HGF)0010 |2 StatID |
| 915 | _ | _ | |a Peer review |0 StatID:(DE-HGF)0030 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 920 | 1 | _ | |k ISB-3 |l Strukturbiochemie |d 31.12.2010 |g ISB |0 I:(DE-Juel1)VDB942 |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)124031 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| 981 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|